Consequences of rpoB mutations missed by the GenoType MTBDR plus assay in a programmatic setting in South Africa
{{output}}
Background: Rifampicin resistance missed by commercial rapid molecular assays but detected by phenotypic assays may lead to discordant susceptibility results and affect patient management. ... ...
